v3.26.1
Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Research and development costs $ 16,680 $ 17,694
Personnel related expenses 3,088 14,467
Professional fees 4,343 1,422
Interest payable 821 840
Operating lease 743 713
Other 241 217
Accrued expenses and other current liabilities $ 25,916 $ 35,353